SL | Jotup

President Biden Selects Julie Brill as 2023 Presidential Rank Awardee

Retrieved on:

Friday, November 3, 2023

OPM, Presidential Rank Awards, Civil Service Reform Act of 1978, Human, Federation, PRA, Senior Executive Service (United States), SL, Pras, Senior, Small business, Science, SES, Culture, SBA, Nursing, Management

WASHINGTON, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Today, Administrator Isabel Guzman , head of the U.S. Small Business Administration (SBA) and the voice for America’s 33 million small businesses in President Biden’s Cabinet is proud to recognize Julie Brill, Deputy Chief Human Capital Officer, as a recipient of the 2023 Presidential Rank Awards (PRA) chosen by President Biden.

Key Points:

WASHINGTON, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Today, Administrator Isabel Guzman , head of the U.S. Small Business Administration (SBA) and the voice for America’s 33 million small businesses in President Biden’s Cabinet is proud to recognize Julie Brill, Deputy Chief Human Capital Officer, as a recipient of the 2023 Presidential Rank Awards (PRA) chosen by President Biden.
“Julie Brill exemplifies the best in public service.
This Presidential Rank Award is not only a recognition of her outstanding service but a testament to the leadership and vision she embodies.
The complete list of the Presidential Rank Awards can be found on OPM's website.

Tonix Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept Study of TNX-601 ER for the Treatment of Major Depressive Disorder

Retrieved on:

Tuesday, October 31, 2023

SAE, Fibromyalgia, SL, NDA, Tonix Pharmaceuticals, Depression, MADRS, Patient, MDD, Major depressive disorder, Pharmaceutical industry

CHATHAM, N.J., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced topline results from the Phase 2 proof-of-concept double-blind, randomized, multi-center, placebo-controlled UPLIFT study of TNX-601 ER* (tianeptine hemioxalate extended-release tablets) in patients with major depressive disorder (MDD). The primary efficacy endpoint of change from baseline in depression severity, as measured by the Montgomery-Åsberg Depression Rating Scale (MADRS) total score, did not achieve clinical or statistical significance.

Key Points:

The primary efficacy endpoint of change from baseline in depression severity, as measured by the Montgomery-Åsberg Depression Rating Scale (MADRS) total score, did not achieve clinical or statistical significance.
“Based on these efficacy results, we are discontinuing development of TNX-601 ER.
We look forward to topline results from our Phase 2 study of TNX-1900 in chronic migraine in early December and topline results from our Phase 3 potential NDA-enabling study of TNX-102 SL in fibromyalgia in late December,” said Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals.
In the study, TNX-601 ER was generally well-tolerated with a favorable safety profile.

SL Green Announces Appointment of Garrett Armwood as Vice President of Government Affairs

Retrieved on:

Monday, October 30, 2023

Government, State Government Affairs Council, SL Green Realty, NYSE, Housing, Electron–ion collider, Brookhaven National Laboratory, State, SL, City, Trust, COVID-19, Co-op City, Bronx, SLG, Senate, New Yorker

NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan’s largest office landlord, today announced that it has appointed Garrett Armwood as Vice President of Government Affairs.

Key Points:

NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan’s largest office landlord, today announced that it has appointed Garrett Armwood as Vice President of Government Affairs.
Armwood most recently served as the Deputy State Director to Senate Majority Leader Charles E. Schumer.
“I’m thrilled to join such a renowned firm as SL Green and play a part in their initiatives to deliver exciting new projects for the city and for New Yorkers,” said Garrett Armwood, Vice President of Government Affairs at SL Green.
I look forward to working with SL Green to continue this work and uplift communities across the city.”

Tonix Pharmaceuticals Announces New Data Involving TNX-1500 (Fc-modified dimeric anti-CD40L mAb) in Heart Xenotransplantation in Animal Models at the ACS Clinical Congress and IPITA-IXA-CTRMS Joint Congress

Retrieved on:

Monday, October 30, 2023

CHATHAM, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced data from two oral presentations which were delivered recently at the American College of Surgeons (ACS) Clinical Congress 2023, and The International Pancreas and Islet Transplant Association (IPITA), the International Xenotransplantation Association (IXA), and the Cell Transplant and Regenerative Medicine Society (CTRMS) Joint Congress by faculty at the Center for Transplantation Sciences, Massachusetts General Hospital (MGH) in October 2023. The data involve Tonix’s TNX-1500 (Fc-modified dimeric anti-CD40L monoclonal antibody [mAb]) which is currently in Phase 1 development for the prevention of organ transplant rejection. Copies of the presentations are available under the Scientific Presentations tab of the Tonix Pharmaceuticals website at www.tonixpharma.com.

Key Points:

The data involve Tonix’s TNX-1500 (Fc-modified dimeric anti-CD40L monoclonal antibody [mAb]) which is currently in Phase 1 development for the prevention of organ transplant rejection.
Copies of the presentations are available under the Scientific Presentations tab of the Tonix Pharmaceuticals website at www.tonixpharma.com .
include data demonstrating the use of TNX-1500 as maintenance therapy after xeno heart transplant in non-human primates.
In both studies, genetically engineered (GE) pigs in baboon transplants were treated with cold-perfused ischemia minimization and a novel costimulation-based immunosuppressive regimen including TNX-1500.

Odyssey Golf Announces New Ai-ONE and Ai-ONE Milled Putters

Retrieved on:

Wednesday, November 1, 2023

Golf, Callaway Golf Company, 2009 European Team Championships, Face, Aluminium, Artificial intelligence, Woman's World, SL, Acushnet Company, Scotty, White hot, PVD, Callaway, Beauty, Medical device, Gunsmith, Phosphorus, Odyssey

CARLSBAD, Calif., Nov. 1, 2023 /PRNewswire/ -- Today Odyssey Golf, an industry leader in putter innovation and the #1 Putter on Tour, announced its exceptional new lineup of Ai-ONE and Ai-ONE Milled Putters.

Key Points:

CARLSBAD, Calif., Nov. 1, 2023 /PRNewswire/ -- Today Odyssey Golf, an industry leader in putter innovation and the #1 Putter on Tour, announced its exceptional new lineup of Ai-ONE and Ai-ONE Milled Putters.
In the new Ai-ONE, Odyssey has leveraged Callaway's industry-leading Artificial Intelligence design and super-computing capabilities to create the most advanced insert in golf.
With Ai-ONE Milled, putts finish closer to the hole on average than a traditional milled putter*.
The Odyssey Ai-ONE Milled family will also be at retail and online on November 3, with a price of $449.99.

Online On-Demand Food Delivery Services Market size to grow by USD 266.05 billion from 2022 to 2027; Market is fragmented due to the presence of prominent companies like Alibaba Group Holding Ltd., Bundl Technologies Pvt. Ltd, Curefoods India Pvt. Ltd., a

Retrieved on:

Thursday, October 26, 2023

Domino's, Grubhub, Grab (company), Higglytown Heroes, SL, Growth, City, Geography, Uber Technologies Inc v Heller, Restaurant, SE, Talabat, USD, Investment, MFS, Food delivery

The online on-demand food delivery services market is fragmented owing to the presence of many global and regional companies.

Key Points:

The online on-demand food delivery services market is fragmented owing to the presence of many global and regional companies.
A few prominent companies that offer online on-demand food delivery services market are Alibaba Group Holding Ltd., Bundl Technologies Pvt.
China and India are some of the key contributors to the online on-demand food delivery services market in APAC.
The mobile food services (MFS) market size is estimated to grow at a CAGR of 8.84% between 2022 and 2027.

Latest news - Next CULT Committee meetings on 27-28 November - Committee on Culture and Education

Retrieved on:

Thursday, October 26, 2023

Access to page content (press "Enter")

Key Points:

Access to page content (press "Enter")
Direct access to language menu (press "Enter")
Direct access to search menu (press "Enter")
EN - English
BG - български
ES - español
CS - čeština
DA - dansk
DE - Deutsch
ET - eesti keel
EL - Ελληνικά
EN - English
FR - français
GA - Gaeilge
HR - hrvatski
IT - italiano
LV - latviešu valoda
LT - lietuvių kalba
HU - magyar
MT - Malti
NL - Nederlands
PL - polski
PT - português
RO - română
SK - slovenčina
SL - slovenščina
FI - suomi
SV - svenska
News
MEPs
About Parliament
Plenary
Committees
Delegations
Other websites
Other websites
News
MEPs
About Parliament
Plenary
Committees
Delegations
Multimedia Centre
President’s website
Secretariat-general
Think tank
EP Newshub
At your service
Visits
Legislative train
Contracts and Grants
Register
Open Data Portal
Liaison offices
Committees
European Parliament
Search
Search
Please fill this field
CULT
European Parliament
Search
Menu
Choose your committee
Choose your committee
All committees - Homepage
Foreign Affairs
Human Rights
Security and Defence
Development
International Trade
Budgets
Budgetary Control
Economic and Monetary Affairs
Tax Matters
Employment and Social Affairs
Environment, Public Health and Food Safety
Public Health
Industry, Research and Energy
Internal Market and Consumer Protection
Transport and Tourism
Regional Development
Agriculture and Rural Development
Fisheries
Culture and Education
Legal Affairs
Civil Liberties, Justice and Home Affairs
Constitutional Affairs
Women’s Rights and Gender Equality
Petitions
Beating Cancer
COVID-19 pandemic: lessons learned and recommendations for the future
Special Committee on foreign interference and disinformation, and on strengthening integrity in the EP
Foreign Interference in all Democratic Processes in the European Union, including Disinformation
Artificial Intelligence in a Digital Age
Protection of Animals during Transport
Use of Pegasus and equivalent surveillance spyware
Go to the page
CULT
Home
Highlights
Members
Press releases
Newsletters
Publications
Subject files
Meetings
Meeting documents
Webstreaming
Votes
Minutes
Documents
Latest documents
Search
Work in progress
Events
Hearings
Workshops
Meetings with National Parliaments
European Citizens’ Initiatives
Supporting analyses
Latest documents
Search
Presentation
About
Go back
CULT
Home
Highlights
Next CULT Committee meetings on 27-28 November
Next CULT Committee meetings on 27-28 November
25-10-2023 - 09:47
Share this page on Facebook
Share this page on Twitter
Share this page on LinkedIn
Autumn © Image used under the license of Adobe Stock
Provisional calendar of CULT Committee meetings for 2023
(PDF - 218 KB)
Provisional calendar of CULT Committee meetings for the first half of 2024
(PDF - 215 KB)
List of CULT Coordinators - as of February 2023
(PDF - 117 KB)
EP calendar 2023
(PDF - 580 KB)

Sasol Chemicals Introduces Biosurfactant Brands for Personal and Home Care Markets

Retrieved on:

Monday, October 23, 2023

Sasol Chemicals, a business unit of Sasol Ltd. (JSE: SOL; NYSE: SSL), today announced the launch of CARINEX and LIVINEX, two brands that will expand Sasol’s offerings of sustainable products.

Key Points:

Sasol Chemicals, a business unit of Sasol Ltd. (JSE: SOL; NYSE: SSL), today announced the launch of CARINEX and LIVINEX, two brands that will expand Sasol’s offerings of sustainable products.
CARINEX SL AND LIVINEX SL, both biosurfactants, are the first product offerings under these new brands.
Sasol Chemicals, one of the world’s largest manufacturers of surfactants, previously announced plans to begin exploring alternatives to traditional surfactants.
“Our partnership with Sasol Chemicals allows us to increase the reach and use of biosurfactants to markets across the globe,” said Richard Lock, Managing Director of Holiferm.

Monroe® Intelligent Suspension Adaptive Dampers from Tenneco Selected for Top Performance vehicle

Retrieved on:

Monday, October 16, 2023

Partnership, SL, Torque, G class, Mercedes-AMG C-Coupé DTM, Mercedes-AMG, Comfort, Formula, OEM, Mercedes, Acceleration, Sint-Truiden, Race, Electric motor, Tenneco

NORTHVILLE, Mich., Oct. 16, 2023 (GLOBE NEWSWIRE) -- The 2023 Mercedes-AMG C 63 S E PERFORMANCE plug-in hybrid will feature Tenneco’s Monroe® Intelligent Suspension CVSA2 electronic dampers.

Key Points:

NORTHVILLE, Mich., Oct. 16, 2023 (GLOBE NEWSWIRE) -- The 2023 Mercedes-AMG C 63 S E PERFORMANCE plug-in hybrid will feature Tenneco’s Monroe® Intelligent Suspension CVSA2 electronic dampers.
CVSA2 technology continuously adjusts damping characteristics based on steering wheel angle, vehicle speed, acceleration, body displacement and other data points.
The same Monroe Intelligent Suspension technology is available in a variety of Mercedes-AMG SL models as well as the G-Class SUV.
The broad adjustment range of the CVSA2 adaptive dampers is well suited to comparatively heavy plug-in hybrid performance cars.

Tonix Pharmaceuticals to Present at the 2023 ThinkEquity Conference

Retrieved on:

Thursday, October 12, 2023

CHATHAM, N.J., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, announced today that Jessica Morris, Chief Operating Officer of Tonix Pharmaceuticals, will present at the ThinkEquity Conference on Thursday, October 19, 2023, at 8:00 a.m.

Key Points:

CHATHAM, N.J., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, announced today that Jessica Morris, Chief Operating Officer of Tonix Pharmaceuticals, will present at the ThinkEquity Conference on Thursday, October 19, 2023, at 8:00 a.m.
Investors interested in arranging a meeting with the Company’s management during the conference should contact the ThinkEquity conference coordinator.
A webcast of the presentation will be available under the IR Events tab of the Tonix website at www.tonixpharma.com .
Tonix is a biopharmaceutical company focused on commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease and alleviate suffering.